Prevention bacterial meningitis Vaccines chemoprophylaxis morbidity mortality bacterial meningitis significant advances antimicrobial therapy supportive care Prevention meningitis routine immunization infants risk practical way incidence disease Widespread use protein conjugate vaccines Haemophilus influenzae type incidence bacterial meningitis half disease pathogens effective vaccine group meningococcus immunogenicity pneumococcal quadrivalent meningococcal vaccines time universal immunization infants immunogenic vaccines possible continued efforts immunization high-risk individuals chemoprophylaxis secondary disease Addendum October Food Drug Administration praxis Haemophilus influenzae type b-protein conjugate vaccine Hboc use infants months age booster dose months statements Immunizations Advisory Committee American Academy Pediatrics official recommendations use 